Rudalf Joseph Corriea

Alivus Life Sciences discloses two upcoming investor/analyst meetings scheduled for May 25 and 27, 2026. Meetings include an in-person group conference with Ambit India and a one-on-one with Abakkus A

Alivus Life Sciences discloses a one-on-one virtual investor meeting with Karma Capital scheduled for May 22, 2026. The intimation is made pursuant to SEBI Listing Regulations 30 and Schedule III. The